Invesco ETF Trust Invesco Dorsey Wright Energy Momentum ETF (PXI) Options

https://drive.proton.me/urls/4YNZRJ8Y50#M7M4SAoQeSzZ

So what’s considered a strong Q1 in everyone’s opinion?
500k. 1 million. 1.5 million

looks like good volume, now. "Bodes well" for me.

Another fine performance by CLNV today. Closer to the .01's every day.

CGC Gap up and run tomorrow. Trending higher in AH

Do you Like the run to $12.80
Next one is coming

WOOOOOOO!!!!

I WIN AGAIN!!! GO BUD!!!


HOW DO ZIGGY & THE KITTEN NOT MAKE MONEY HERE?!!!!!!!

HAHAHAHA!!!!

OH WELL, GREEN GRASSHOPPER GOES CHOMP CHOMP CHOMP!!!!

LITTLE KITTENS GO MEOW MEOW!!!! SOUR PUSSES!!!

Strike a nerve?? or should I keep drilling? BTC 6 digits coming soon, Mark it. Unlike the clickbait you believe. LMFAO

Your consistent efforts to make this about the posters on the board does NOT change the facts I presented about DBMM.

Let's keep on the board topic, shall we?

What is the problem? Don't want to talk about DBMM's failures??

I do not blame you a bit.

Either way, I’m long! I won’t be going anywhere!

This "Show" is about to get a lot better.

Excellent -

Collegium Reports First Quarter 2024 Financial Results

May 9, 2024

– Generated Q1’24 Net Revenue of $144.9 Million –

– Delivered Q1’24 Record Belbuca® Revenue of $50.7 Million; Total Prescriptions Up 4.2% Year-over-Year –

Total Nonsense

Small dog having a great time.

Note that the slide rider does much better on stairs than the MMP (mummified meat puppet) Biden

https://twitter.com/AMAZlNGNATURE/status/1788539660530016290?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1788539660530016290%7Ctwgr%5E

Nobody was expecting a homerun here. Not bad, I suppose.

Rembrandt strikes again!

Ty SBSS. Great presentation imo. Great expectations of approval still hanging with in the next year.

GVSI continues to creep upwards

Good work, BUDDY!

Thanks for taking the time to do that and then let us know..

Very cool...

Keep up the good work..

Q1 is out.

https://investors.revance.com/investors/Press-Releases/news-details/2024/Revance-Reports-First-Quarter-2024-Financial-Results-Provides-Corporate-Update/default.aspx

- Total net product revenue (DAXXIFY® and RHA® Collection) of $51.7 million, a YoY i

Term sheets (think GSA) could've preserved first right of refusal purchase rights by JPM after any TARP statute of limitation expired..if BBob statement is even actually true. Could explain why this has taken so friggin long. In other words, both statement could be right. A person could say it w

Saw this on another board . . .
Remember this is an opportunity that doesn't come along often.
They must be new to OTC. This "opportunity" comes along all the time. Literally. Every day.

Most MAD studies do a 3 + 3 design. Enroll three at lowest (first) Dose then move to next dose if 0 patients have toxicity. If one has toxicity do three more patients and move to next dose if none of these have toxicity. Each dose is a cohort so each cohort has either 3 or 6

Most MAD studies do a 3 + 3 design. Enroll three at lowest (first) Dose then move to next dose if 0 patients have toxicity. If one has toxicity do three more patients and move to next dose if none of these have toxicity. Each dose is a cohort so each cohort has either 3 or 6

PJ, I just checked and the IPIX views are now 6,522. That sort of activity demonstrates a huge amount of interest in this so-called "dead" company.